No Data
No Data
Trump has initiated a 232 investigation and plans to impose tariffs on Semiconductors and Pharmaceuticals.
The Trump administration officially launched investigations into the National Security of Semiconductors and Pharmaceuticals, paving the way for further tariff increases.
Guggenheim Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Cuts Target Price to $928
Is Now The Time To Put Eli Lilly (NYSE:LLY) On Your Watchlist?
President Trump Says Will Do Tariffs On Imported Pharmaceuticals; All I Have To Do Is Impose A Tariff; Pharmaceutical Tariffs In Not Too Distant Future
Verve Therapeutics Touts Positive Data From Gene Editing Medicine To Lower Cholesterol After Single Dose
Viking, Structure, Metsera on a Tear as Pfizer Drops Obesity Pill